Atlas Trials

Conjupro Biotherapeutics, Inc.

10 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Conjupro Biotherapeutics, Inc.

RecordFirmDate
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors (NCT07424547)Conjupro Biotherapeutics, Inc.2026-03-03
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors (NCT07317505)Conjupro Biotherapeutics, Inc.2025-12-02
NBP in Women With Metastatic Breast Cancer to Prevent Nab-paclitaxel Induced Toxic Neuropathy (NCT04675450)Conjupro Biotherapeutics, Inc.2023-06-30
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors (NCT05948865)Conjupro Biotherapeutics, Inc.2023-06-06
Dose Escalation and Expansion Study of CPO102, an Anti-claudin 18.2 ADC in Patients With Advanced Cancers (NCT05043987)Conjupro Biotherapeutics, Inc.2022-11-16
Dose Escalation and Expansion Study of CPO107 for Patients With Advanced CD20-positive Non-Hodgkins Lymphoma (NCT04853329)Conjupro Biotherapeutics, Inc.2021-12-13
Single and Multiple Doses of HA115 and Food Effect in Healthy Adult Volunteers (NCT03567694)Conjupro Biotherapeutics, Inc.2021-10-01
Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors (NCT04931823)Conjupro Biotherapeutics, Inc.2021-03-24
PLM60 for Peripheral T Cell Lymphoma (PTCL) (NCT03553914)Conjupro Biotherapeutics, Inc.2021-01-01
Bioavailability of 5 mg of Levamlodipine Maleate Tablets Versus 10 mg of Amlodipine Besylate Tablet in Healthy Subjects (NCT03657550)Conjupro Biotherapeutics, Inc.2018-05-31

Track Conjupro Biotherapeutics, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.